Kun‐Chieh Chen

1.9k total citations
15 papers, 458 citations indexed

About

Kun‐Chieh Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kun‐Chieh Chen has authored 15 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kun‐Chieh Chen's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (7 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Kun‐Chieh Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (7 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Kun‐Chieh Chen collaborates with scholars based in Taiwan, United States and Canada. Kun‐Chieh Chen's co-authors include Tsung‐Ying Yang, Gee‐Chen Chang, Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Chih‐Yi Chen, Chien‐Hua Tseng, Sung‐Liang Yu, Wen‐Chung Lee, Tsang-Wu Liu and Ben‐Jei Tsuang and has published in prestigious journals such as Cancer, Clinical Cancer Research and Oncotarget.

In The Last Decade

Kun‐Chieh Chen

15 papers receiving 450 citations

Peers

Kun‐Chieh Chen

PRM

ONCOL

HTM

Daojuan Li China

Wenxi Yu China

Hae-Seong Nam South Korea

Elaine M. Walsh United States

Jae‐Uk Jeong South Korea

You Guo China

Zhenfa Zhang China

Anna Gasińska Poland

Yong-Qiao He China

Huilin Xu China

Daojuan Li China

Kun‐Chieh Chen

144 ×0.6

PRM

169 ×1.0

ONCOL

171 ×1.1

103 ×1.3

50 ×0.8

HTM

Citations per year, relative to Kun‐Chieh Chen Kun‐Chieh Chen (= 1×) peers Daojuan Li

Countries citing papers authored by Kun‐Chieh Chen

Since Specialization

Citations

This map shows the geographic impact of Kun‐Chieh Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun‐Chieh Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun‐Chieh Chen more than expected).

Fields of papers citing papers by Kun‐Chieh Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun‐Chieh Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun‐Chieh Chen. The network helps show where Kun‐Chieh Chen may publish in the future.

Co-authorship network of co-authors of Kun‐Chieh Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Kun‐Chieh Chen. A scholar is included among the top collaborators of Kun‐Chieh Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun‐Chieh Chen. Kun‐Chieh Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hsu, Kuo-Hsuan, et al.. (2024). Osimertinib as Second- and ≥Third-Line Treatment in Advanced and Recurrence EGFR-Mutant NSCLC Patients Harboring Acquired T790M Mutation. Cancers. 16(24). 4174–4174. 1 indexed citations

Chao, Heng‐Sheng, et al.. (2023). Artificial Intelligence Assisted Computational Tomographic Detection of Lung Nodules for Prognostic Cancer Examination: A Large-Scale Clinical Trial. Biomedicines. 11(1). 147–147. 9 indexed citations

Huang, Yen-Hsiang, Kun‐Chieh Chen, Kuo-Hsuan Hsu, et al.. (2022). Reactivation of Hepatitis B Virus in Lung Cancer Patients Receiving Tyrosine Kinase Inhibitor Treatment. Journal of Clinical Medicine. 12(1). 231–231. 6 indexed citations

Huang, Yen-Hsiang, Ho Lin, Kuo-Hsuan Hsu, et al.. (2022). Histological Transformation after Acquired Resistance to the Third-Generation EGFR-TKI in Patients with Advanced EGFR-Mutant Lung Adenocarcinoma. Medicina. 58(7). 908–908. 4 indexed citations

Su, Kang‐Yi, Ming-Hsi Sun, Kun‐Chieh Chen, et al.. (2022). Influence of the Timing of Leptomeningeal Metastasis on the Outcome of EGFR-Mutant Lung Adenocarcinoma Patients and Predictors of Detectable EGFR Mutations in Cerebrospinal Fluid. Cancers. 14(12). 2824–2824. 1 indexed citations

Hsu, Kuo-Hsuan, Jing-Wen Huang, Jeng‐Sen Tseng, et al.. (2021). Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naïve Advanced EGFR-Mutant Lung Adenocarcinoma Patients. OncoTargets and Therapy. Volume 14. 2139–2148. 11 indexed citations

Wu, Chih‐Ying, Chih-Liang Wang, Tsung‐Ying Yang, et al.. (2020). Impact of tumor disappearance ratio on the prognosis of lung adenocarcinoma ≤2 cm in size: A retrospective cohort study. Journal of the Formosan Medical Association. 120(2). 874–882. 1 indexed citations

Tseng, Chien‐Hua, Ben‐Jei Tsuang, Chun‐Ju Chiang, et al.. (2019). The Relationship Between Air Pollution and Lung Cancer in Nonsmokers in Taiwan. Journal of Thoracic Oncology. 14(5). 784–792. 139 indexed citations

Chang, Gee‐Chen, Chien‐Hua Tseng, Kuo-Hsuan Hsu, et al.. (2016). Predictive factors for EGFR -tyrosine kinase inhibitor retreatment in patients with EGFR -mutated non-small-cell lung cancer – A multicenter retrospective SEQUENCE study. Lung Cancer. 104. 58–64. 20 indexed citations

10.

Hsu, Kuo-Hsuan, Jeng‐Sen Tseng, Chih-Liang Wang, et al.. (2016). Higher frequency but random distribution of EGFR mutation subtypes in familial lung cancer patients. Oncotarget. 7(33). 53299–53308. 6 indexed citations

11.

Tseng, Jeng‐Sen, Chih-Liang Wang, Tsung‐Ying Yang, et al.. (2015). Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma. Lung Cancer. 90(3). 472–476. 13 indexed citations

12.

Yang, Shi‐Yi, Tsung‐Ying Yang, Kun‐Chieh Chen, et al.. (2011). EGFR L858R Mutation and Polymorphisms of Genes Related to Estrogen Biosynthesis and Metabolism in Never-Smoking Female Lung Adenocarcinoma Patients. Clinical Cancer Research. 17(8). 2149–2158. 26 indexed citations

13.

Hsu, Kuo-Hsuan, Kun‐Chieh Chen, Tsung‐Ying Yang, et al.. (2011). Epidermal Growth Factor Receptor Mutation Status in Stage I Lung Adenocarcinoma with Different Image Patterns. Journal of Thoracic Oncology. 6(6). 1066–1072. 42 indexed citations

14.

Chang, Gee‐Chen, Ko‐Jiunn Liu, Chia‐Ling Hsieh, et al.. (2006). Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes. Clinical Cancer Research. 12(19). 5746–5754. 128 indexed citations

15.

Yang, James Chih‐Hsin, Jin‐Yuan Shih, Kun‐Chieh Chen, et al.. (2006). Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer. Cancer. 107(8). 1873–1882. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact